PTIX Stock Chart

Protagenic Therapeutics is a biotechnology company focusing on developing natural human brain hormones to treat mood disorders. The Company has created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. The lead product candidate, PT00114, is targeted to inhibit anxiety and depression without interfering with normal brain function.